HEMACORE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

HEMACORE Trademark

Serial Number: 79300391 • Registration: 6733679

HEMACORE is a trademark filed by Limited Liability Company "Hematological Corporation" on August 20, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Limited Liability Company "Hematological Corporation" (4 trademarks)

Nauchniy proezd, dom 20, stroenie 2

Entity Type: 16

Trademark Details

Filing Date

August 20, 2020

Registration Date

May 24, 2022

Published for Opposition

March 8, 2022

Goods & Services

Testing apparatus not for medical purposes, namely, for testing biological compounds; monitoring apparatus, other than for medical purposes, namely, for monitoring of spatiotemporal dynamics of biochemical reactions; apparatus and instruments for physics, namely, thermostats, pressure indicators, temperature indicators; chemistry apparatus and instruments, namely, scattering meters, spectrophotometers; measuring apparatus, namely, for measuring of spatiotemporal dynamics of biochemical reactions; computer programs, recorded for scientific, biological and medical purposes for performing tests and processing data; computer software, recorded, for scientific, biological and medical purposes for performing tests and processing data

Blood plasma, namely, for the diagnosis of hemostasis; albuminous preparations for medical purposes, namely, for the diagnosis and treatment of hemostatic disorders; biological preparations for medical purposes, namely, for the diagnosis and treatment of hemostatic disorders; diagnostic preparations for medical purposes; enzyme preparations for medical purposes, namely, for the diagnosis and treatment of hemostatic disorders; chemical reagents for medical or veterinary purposes, namely, for the diagnosis and treatment of hemostatic disorders; salts, namely, sodium salts, calcium salts, for medical purposes, namely, for the diagnosis and treatment of hemostatic disorders; enzymes for medical purposes, namely, for the diagnosis and treatment of hemostatic disorders

Testing apparatus for medical purposes, namely, for the diagnosis of hemostasis; blood testing apparatus, namely, for the diagnosis of hemostasis; diagnostic apparatus for medical purposes, namely, for the diagnosis of hemostasis; medical apparatus and instruments, namely, for the diagnosis and treatment of hemostasis disorders

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 17, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Sep 7, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 7, 2022 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 24, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 24, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
May 24, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Mar 13, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 8, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 16, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 16, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 16, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 28, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 6, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 30, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jul 30, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jul 30, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 25, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 24, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 24, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 16, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 16, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 16, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 16, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 16, 2021 COAR
REFUSAL PROCESSED BY IB
Feb 14, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 26, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jan 25, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 5, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jan 4, 2021 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 2, 2021 MAFR
ASSIGNED TO EXAMINER
Dec 29, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 29, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 24, 2020 REPR